<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137802">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01828281</url>
  </required_header>
  <id_info>
    <org_study_id>VF-CPAP</org_study_id>
    <nct_id>NCT01828281</nct_id>
  </id_info>
  <brief_title>Effects of CPAP on Visceral Fat Thickness</brief_title>
  <official_title>A Randomized Controlled Study on the Effects of CPAP on Visceral Fat Thickness, Carotid Intima-media Thickness and Adipokines in Patients With Obstructive Sleep Apnoea Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <authority>Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize that patients with untreated OSAS will have more visceral fat, fatty liver
      and increased carotid artery thickness whereas treatment with CPAP may reduce the mesenteric
      and liver fat, plasma lipids, carotid artery thickness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This proposed RCT will compare the effects of therapeutic CPAP versus subtherapeutic CPAP in
      patients newly diagnosed with OSA with reference to visceral fat especially mesenteric fat
      thickness, liver fat, carotid artery IMT, LPW thickness, plasma lipids and adipokines over a
      treatment period of 3 months. The results of this study will advance our understanding of
      the relative role of OSA and obesity in the pathogenesis of MetS and whether CPAP therapy
      can improve these metabolic dysregulation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>mesenteric fat thickness</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in adipokines</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>CPAP usage</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Therapeutic CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Therapeutic CPAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>subtherapeutic CPAP using 4 cm water</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>All subjects will undergo ultrasound examination of the abdomen the day after overnight PSG and then at 3 months after completion of therapeutic or subtherapeutic CPAP treatment of 4 cm water.</description>
    <arm_group_label>Therapeutic CPAP</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic patients with OSA of AHI &gt;= 5/hr

        Exclusion Criteria:

          -  Recent or past history of myocardial infarction/stroke/heart failure, unstable
             angina, underlying malignancy,

          -  patients with clinical features of any active infection

          -  those who require urgent CPAP treatment because of associated respiratory failure or
             to prevent job loss through excessive daytime sleepiness (eg professional drivers,
             those handling dangerous machinery)

          -  moderate to severe valvular heart disease, cardiomyopathy, and previous diagnosis of
             OSA and/or previous use of CPAP therapy.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hui David, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karen Yiu</last_name>
    <phone>852 26323532</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Respiratory Division</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Yiu</last_name>
      <phone>852 26323532</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 8, 2013</lastchanged_date>
  <firstreceived_date>April 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Prof David Shu Cheong Hui</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
